Article Details

CT biotech firm secures $9M to advance oral treatment for inflammatory bowel disease

Retrieved on: 2025-01-09 16:29:44

Tags for this article:

Click the tags to see associated articles and topics

CT biotech firm secures $9M to advance oral treatment for inflammatory bowel disease. View article details on hiswai:

Excerpt

A clinical-stage pharmaceutical company based in Essex, Thetis Pharmaceuticals LLC, has secured $9 million in funding in the form of a loan from ...

Article found on: www.hartfordbusiness.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up